




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
H.I.V.WHATISHIV??“HumanImmunodeficiencyVirus”Auniquetypeofvirus(aretrovirus)InvadesthehelperTcells(CD4cells)inthebodyofthehost(defensemechanismofaperson)Threateningaglobalepidemic.Preventable,managablebutnotcurable.OTHERNAMESFORHIVFormernamesofthevirusinclude:HumanTcelllymphotrophicvirus(HTLV-III)Lymphadenopathyassociatedvirus(LAV)AIDSassociatedretrovirus(ARV)WHATISAIDS???“AcquiredImmunodeficiencySyndrome”HIVisthevirusthatcausesAIDSDiseaselimitsthebody’sabilitytofightinfectionduetomarkedlyreducedhelperTcells.Patientshaveaveryweakimmunesystem(defensemechanism)Patientspredisposedtomultipleopportunisticinfectionsleadingtodeath.AIDS(definition)Opportunisticinfectionsandmalignanciesthatrarelyoccurintheabsenceofsevereimmunodeficiency(eg,Pneumocystispneumonia,centralnervoussystemlymphoma).PersonswithpositiveHIVserologywhohaveeverhadaCD4lymphocytecountbelow200cells/mcLoraCD4lymphocytepercentagebelow14%areconsideredtohaveAIDS.“THEVIRALGENOME”Icosahedral(20sided),envelopedvirusofthelentivirussubfamilyofretroviruses.RetrovirusestranscribeRNAtoDNA.TwoviralstrandsofRNAfoundincoresurroundedbyproteinoutercoat.Outerenvelopecontainsalipidmatrixwithinwhichspecificviralglycoproteinsareimbedded.Theseknob-likestructuresresponsibleforbindingtotargetcell.ModesofHIV/AIDSTransmissionThroughBodilyFluidsBloodproductsSemenVaginalfluidsIntraVenousDrugAbuseSharingNeedlesWithoutsterilizationIncreasesthechancesofcontractingHIVUnsterilizedbladesThroughSexUnprotectedIntercourseOralAnalMother-to-BabyBeforeBirthDuringBirthMythsabouttransmissionNATURALCOURSEOFHIV/AIDSStage1-PrimaryShort,flu-likeillness-occursonetosixweeksafterinfectionMildsymptomsInfectedpersoncaninfectotherpeopleStage2-AsymptomaticLastsforanaverageoftenyearsThisstageisfreefromsymptomsTheremaybeswollenglandsThelevelofHIVintheblooddropstolowlevelsHIVantibodiesaredetectableinthebloodStage3-SymptomaticTheimmunesystemdeterioratesOpportunisticinfectionsandcancersstarttoappear.Stage4-HIVAIDSTheimmunesystemweakenstoomuchasCD4cellsdecreaseinnumber.OpportunisticInfectionsassociatedwithAIDSCD4<500BacterialinfectionsTuberculosis(TB)HerpesSimplexHerpesZosterVaginalcandidiasisHairyleukoplakiaKaposi’ssarcomaOpportunisticInfectionsassociatedwithAIDSCD4<200PneumocysticcariniiToxoplasmosisCryptococcosisCoccidiodomycosisCryptosporiosisNonhodgkin’slymphomaCD4<50Disseminatedmycobacteriumaviumcomplex(MAC)infectionHistoplasmosisCMVretinitisCNSlymphomaProgressivemultifocalleukoencephalopathyHIVdementiaTB&HIVCO-INFECTIONTBisthemostcommonopportunisticinfectioninHIVandthefirstcauseofmortalityinHIVinfectedpatients(10-30%)10millionpatientsco-infectedintheworld.ImmunosuppressioninducedbyHIVmodifiestheclinicalpresentationofTB:Subnormalclinicalandroentgen
presentationHighrateofMDR/XDRHighrateoftreatmentfailureandrelapse(5%vs<1%inHIV)TestingOptionsforHIVAnonymousTestingNonameisusedUniqueidentifyingnumberResultsissuedonlytotestrecipient23659874515AnonymousBloodDetectionTestsHIVenzyme-linkedimmunosorbentassay(ELISA)ScreeningtestforHIVSensitivity>99.9%WesternblotConfirmatorytestSpeicificity>99.9%(whencombinedwithELIZA)HIVrapidantibodytestScreeningtestforHIVSimpletoperformAbsoluteCD4lymphocytecountPredictorofHIVprogressionRiskofopportunisticinfectionsandAIDSwhen<200HIVviralloadtestsBesttestfordiagnosisofacuteHIVinfectionCorrelateswithdiseaseprogressionandresponsetoHAARTUrineTestingUrineWesternBlotAssensitiveastestingbloodSafewaytoscreenforHIVCancausefalsepositivesincertainpeopleathighriskforHIVOralTestingOrasureTheonlyFDAapprovedHIVantibody.AsaccurateasbloodtestingDrawsblood-derivedfluidsfromthegumtissue.NOTASALIVATEST!TreatmentOptionsHAART=highlyactiveanti-retroviraltreatmentAntiretroviralDrugs(HAART)NucleosideReverseTranscriptaseinhibitorsAZT(Zidovudine)Non-NucleosideTranscriptaseinhibitorsViramune(Nevirapine)ProteaseinhibitorsNorvir(Ritonavir)EFFECTIVENESSOFHAARTINREDUCINGMORTALITYHEALTHCAREFOLLOWUPOFHIVINFECTEDPATIENTSForallHIV-infectedindividuals:
CD4countsevery3–6months
Viralloadtestsevery3–6monthsand1monthfollowingachangeintherapy
PPD
INHforthosewithpositivePPDandnormalchestradiograph
RPRorVDRLforsyphilis
ToxoplasmaIgGserology
CMVIgGserology
Pneumococcalvaccine
Influenzavaccineinseason
HepatitisBvaccineforthosewhoareHBsAb-negative
Haemophilusinfluenzaetypebvaccination
Papanicolaousmearsevery6monthsforwomenForHIV-infectedindividualswithCD4<200cells/mcL:
Pneumocystisjiroveci1prophylaxis
ForHIV-infectedindividualswithCD4<75cells/mcL:
Mycobacteriumaviumcomplexprophylaxis
ForHIV-infectedindividualswithCD4<50cells/mcL:
ConsiderCMVprophylaxisPRIMARYPREVENTION:
Fivewaystoprotectyourself?AbstinenceMonogamousRelationshipProtectedSexSterileneedlesNewshaving/cuttingbladesAbstinenceItisthemosteffectivemethodofnotacquiringHIV/AIDS.Refrainingfromunprotectedsex:oral,anal,orvaginal.RefrainingfromintravenousdruguseMonogamousrelationshipAmutuallymonogamous(onlyonesexpartner)relationshipwithapersonwhoisnotinfectedwithHIVHIVtestingbeforeintercourseisnecessarytoproveyourpartnerisnotinfectedProtectedSexUsecondomseverytimeyouhavesexAlwaysuselatexorpolyurethanecondom(notanaturalskincondom)AlwaysusealatexbarrierduringoralsexWhenUsingACondomRememberTo:MakesurethepackageisnotexpiredMakesuretocheckthepackagefordamagesDonotopenthepackagewithyourteethforriskoftearingNeverusethecondommorethanonceUsewater-basedratherthanoil-basedcondomsGLOBALESTIMATES2008ESCALATINGEPIDEMIC!!!Source:WHO/UNAIDS/UNTheMillenniumDevelopmentGoalsReport,2009,p.32andWHO.HIVPREVALENCEINVARIOUSREGIONSSource:UNAIDS,AIDSEpidemicUpdate,December2004.Total=39.4millionSub-SaharanAfricaSouth/South-EastAsiaOceaniaCaribbeanNorthAfrica/MiddleEastWesternEuropeNorthAmericaEastAsiaEurasiaLatinAmerica<42%NEWLYINFECTEDCASESOFHIVINVARIOUSREGIONSSource:UNAIDS,AIDSEpidemicUpdate,December2004Total=4.9million63%ESTIMATEDHIVBURDENINPAKISTAN0.1%oftheadultpopulationinPakistanTotalPopulation(2008)=180,800,000PeoplelivingwithHIV/AIDS(2008)=96,000Women(aged15+)withHIV/AIDS(2008)=27,000ChildrenwithHIV/AIDS(2008)=ndAdultHIVprevalence(%)(2008)=0.1%AIDSdeaths(2008)=5,100ESCALATINGEPIDEMICOFHIVINHIGHRISKGROUPSINPAKISTANPOTENTIALTHREATSINPAKISTAN100,000commercialsexworkerswithpoorsafesexawarenessinthreemajorcitiesEstimated60,000ivdrugusersinpakistan(1in5infectedwithHIV)38,000homosexualsreportedinlahorein200240%of1.5millionannualblooddonorsnotscreenedforHIV20%ofbloodtransfusionscomefromprofessionaldonorswithhighprevalenceofinfectiousdiseasesSignificantlylargenumberofmigrantsandrefugees.UNDER-REPORTINGUntilSeptember2004,only300casesoffull-blownAIDSandanother2300casesofHIVinfectionwerereportedtotheNationalAIDSControlProgram.Thereasonsforunderreportingare:Socialstigmaattachedtotheinfection,LimitedsurveillanceVoluntarycounselingandtestingsystemsLackofknowledgeamongthegeneralpopulationandhealthpractitioners.NATIONALRESPONSETOHIV/AIDSPakistan’sFederalMinistryofHealthinitiatedaNationalAIDSPreventionandControlProgram(NACP)in1987Initsearlystages,theprogramwasfocusedondiagnosisofcasesthatcametohospitals,butprogressivelybegantoshifttowardacommunityfocusThegovernmenthasindicatedintherecentscalingupofitsresponsetoHIV/AIDS,moreneedstobedone.NONGOVERNMENTALORGANIZATIONS54NGOsareinvolvedinHIV/AIDSpublicawarenessandinthecareandsupportofpersonslivingwithHIV/AIDS.Alsoworkingoneducationandpreventioninterventionstargetingsexworkers,truckdriv
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- NaOH-Na2CO3复合碱烧结法从二次铝灰中提取氧化铝的研究
- 绿色创新失败对企业再创新的影响研究
- H消防设备公司市场竞争力提升策略研究
- 正渗透-膜蒸馏绿色技术用于苹果汁非热浓缩的研究
- 副猪革拉瑟氏菌vtaA3基因缺失株的生物学特性研究及重组蛋白的免疫效果评价
- 丝绢纺织企业ESG实践与创新战略研究报告
- 香菇调味基料制备过程中的风味特性、理化性质及生物活性变化研究
- 技术水平对基层农技人员增值服务取酬的影响研究
- 仿制药注册资料翻译服务行业跨境出海战略研究报告
- 棉制针织衫企业ESG实践与创新战略研究报告
- 中国古代服饰文化135张课件
- 《道德与法治》五下第一单元《我们一家人》教案
- 拔罐技术操作流程图
- 真空泵日常操作标准作业指导书
- 钢筋保护层厚度试验检测记录表
- 南宁市海绵城市规划设计导则-图文课件
- 阶段1 古代中华文明的起源与奠基-先秦 课时1 先秦时期的社会经济 课件-2022届高三历史一轮复习
- 电焊工安全教育培训课件
- 公共关系理论与实务ppt课件(完整版)
- 外研版五年级下册小学英语全册教学课件PPT
- 中国石油大学(华东)-朱超-答辩通用PPT模板
评论
0/150
提交评论